Immunostimulatory DNA Is a Potent Mucosal Adjuvant
Authors:
- Anthony A. HornerAHAnthony A. Horner
- Arash RonaghyARArash Ronaghy
- Pei-Ming ChengPCPei-Ming Cheng
- Minh-Duc NguyenMNMinh-Duc Nguyen
- Hearn J. ChoHCHearn J. Cho
- David BroideDBDavid Broide
- Eyal RazEREyal Raz
- 1 November 1998
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 190 (1) , 77-82
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Progress in the Development of an HIV-1 VaccineScience, 1998
- Immunostimulatory DNA sequences function as T helper-1-promoting adjuvantsNature Medicine, 1997
- BCL-2 antisense therapy in patients with non-Hodgkin lymphomaThe Lancet, 1997
- HIV Type 1 Vaccine-Induced Cytotoxic T Cell Responses: Potential Role in Vaccine EfficacyAIDS Research and Human Retroviruses, 1997
- Oral but Not Parenteral Interleukin (IL)-12 Redirects T Helper 2 (Th2)-type Responses to an Oral Vaccine Without Altering Mucosal IgA ResponsesJournal of Experimental Medicine, 1997
- Immune Activation by Bacterial DNA: A New Genetic CodeImmunity, 1996
- Activation of human B cells by phosphorothioate oligodeoxynucleotides.Journal of Clinical Investigation, 1996
- Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene ImmunizationScience, 1996
- Adjuvants for human vaccines—current status, problems and future prospectsVaccine, 1995
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989